United Kingdom

People: Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

9:00pm BST
Change (% chg)

$0.69 (+3.72%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Demopulos, Gregory 

Dr. Gregory A. Demopulos, M.D., is Chairman of the Board, President, Chief Executive Officer of Omeros Corp. He also served as our chief financial officer and treasurer from January 2009 to October 2013 in an interim capacity and as our chief medical officer from June 1994 to March 2010. Prior to founding Omeros, Dr. Demopulos completed his residency in orthopedic surgery at Stanford University and his fellowship training in hand and microvascular surgery at Duke University. Dr. Demopulos currently serves on the board of trustees of the Smead Funds Trust, an open-end mutual fund company registered under the Investment Company Act of 1940. Dr. Demopulos received his M.D. from the Stanford University School of Medicine and his B.S. from Stanford University. Our nominating and governance committee has concluded that Dr. Demopulos should continue to serve on the board of directors based on his position and experience as our chief executive officer and his medical and scientific expertise, experience with clinical development and design and knowledge of our operations and development programs. Dr. Demopulos is the brother of Peter A. Demopulos, M.D., a member of our board of directors.

Basic Compensation

Total Annual Compensation, USD 1,470,480
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 3,269,860
Fiscal Year Total, USD 4,740,340

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 142,001 2,365,120.00